Sélectionnez la région qui correspond le mieux à votre emplacement ou à vos préférences.
Ce paramètre contrôle la langue de l'interface utilisateur, y compris les boutons, les menus et tout le texte du site. Sélectionnez votre langue préférée pour une meilleure expérience de navigation.
Sélectionnez les langues des offres d'emploi que vous souhaitez voir. Ce paramètre détermine quelles annonces d'emploi vous seront affichées.
→ Apply until 08/07/2025 (DD/MM/YYYY) 23:59 (Brussels time)
→ Faculty of Medicine and Health Sciences
→ Department GE31 - Department of Biomolecular Medicine
→ AAP temporary appointment - 100%
→ Number of openings: 1
→ Reference number: 202505/GE31/AS/019
ABOUT GHENT UNIVERSITY
Ghent University is a world of its own. Employing 15.000 people, it is actively involved in education and research, management and administration, and technical and social services on a daily basis. It is one of the largest, most exciting employers in the area and offers great career opportunities. With each of its 11 faculties and more than 100 departments offering state-of-the-art study programmes that are grounded in research in a wide range of academic fields, Ghent University is a logical choice for its employees as well as its students.
YOUR TASKS
Subject of the dissertation: BE-PRIORITY - Advancing precision medicine in pediatric oncology through multi-omics
Cancer remains the leading cause of disease-related mortality among young children in developed countries. Precision medicine offers a transformative approach by tailoring treatment decisions to the unique molecular characteristics of each patient’s tumor. However, while companion diagnostic tests for targeted therapies are increasingly available for adult cancers, their utility in pediatric oncology is limited due to small patient populations and the scarcity of effective biomarkers. International precision oncology initiatives have demonstrated the feasibility and clinical impact of comprehensive molecular profiling in guiding personalized therapies for children with cancer. We launch BE-PRIORITY (Belgian Precision Medicine Program for Pediatric Oncology), Belgium’s first national precision medicine initiative for childhood cancer, that aims to implement individualized therapeutic strategies through advanced molecular diagnostics, adopting and optimizing standards and methodologies proven effective by our international counterparts.
The first stage of the project focuses on implementing and optimizing an ultra-fast, comprehensive multi-omics workflow, utilizing single-molecule sequencing to simultaneously profile the genome, transcriptome, chromatine accessibility and methylome. This study will encompass all pediatric solid tumor types (neuroblastoma, sarcoma and brain tumors), with an anticipated annual cohort of approximately 250 patients. Newly identified therapeutic targets will undergo functional validation using ex vivo patient-derived organoids and in vivo patient-derived zebrafish and murine xenograft models.
WHAT WE ARE LOOKING FOR
WHAT WE CAN OFFER YOU
The interview will take place on Friday July 18, 2025.
INTERESTED?
Apply online through the e-recruitment system before the application deadline (see above). We do not accept late applications or applications that are not sent through the online system.
Your application must include the following documents:
Note that the maximum file size for each field is 10 MB.
As Ghent University maintains an equal opportunities and diversity policy, everyone is encouraged to apply for this position.
MORE INFORMATION
For more information about this vacancy, please contact Prof. Björn Menten ([email protected], +32 9 332 52 84) and prof. Kaat Durinck ([email protected], +32 9 332 24 59).
Do you have a question regarding the online application process? Please read the FAQ or contact us via [email protected] or +32 9 264 34 36
Ghent University is one of the top 100 universities in the Dutch language area, with more than 44,000 students and 15,000 staff members.
Visitez la page de l'employeur